India, May 1 -- Cell and gene therapies (CGTs) are often associated with oncology and rare diseases. What's the evolving scope of CGT in modern medicine today?

Cell and gene therapies are moving well beyond their original territory of oncology and rare monogenic disorders. We are now seeing serious research into CGT for autoimmune conditions, metabolic disorders, regenerative medicine, and increasingly for infectious diseases. Gene therapies are being investigated for viral infections like HIV and hepatitis, and more recently for multidrug-resistant bacterial pathogens. The clinical relevance of these platforms is broadening significantly.

A big part of this evolution is CRISPR-based precision editing, which allows selective modificatio...